Literature DB >> 7168316

Studies on a collection of strains of the genus Flavobacterium. 1. Biochemical studies.

B Bruun.   

Abstract

The genus Flavobacterium has undergone a number of changes during the last years resulting in a revised description of the genus in which restriction of Flavobacterium to certain low G + C content species is proposed. The purpose of the present study has been to see how a collection of 184 clinical and environmental strains of Flavobacterium-like organisms isolated in Denmark would fit into this latest revision. It was found that most of the different biochemical patterns represented gradually merged into each other, with certain patterns, however, occurring more frequently than others and corresponding to the already described taxa: F. meningosepticum, Flavobacterium group IIb, F. breve, F. odoratum, F. multivorum and F. spiritivorum. The lately proposed subdivision of the genus will need either revision or extension or both to cope satisfactorily with the situation revealed in this study.

Entities:  

Mesh:

Year:  1982        PMID: 7168316     DOI: 10.1111/j.1699-0463.1982.tb00140.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Immunol Scand B        ISSN: 0108-0180


  2 in total

1.  Revisiting the taxonomy of the genus Elizabethkingia using whole-genome sequencing, optical mapping, and MALDI-TOF, along with proposal of three novel Elizabethkingia species: Elizabethkingia bruuniana sp. nov., Elizabethkingia ursingii sp. nov., and Elizabethkingia occulta sp. nov.

Authors:  Ainsley C Nicholson; Christopher A Gulvik; Anne M Whitney; Ben W Humrighouse; James Graziano; Brian Emery; Melissa Bell; Vladimir Loparev; Phalasy Juieng; Jarrett Gartin; Chantal Bizet; Dominique Clermont; Alexis Criscuolo; Sylvain Brisse; John R McQuiston
Journal:  Antonie Van Leeuwenhoek       Date:  2017-08-30       Impact factor: 2.271

2.  Flavobacterium meningosepticum infection in a neonatal ward.

Authors:  B Bruun; E T Jensen; K Lundstrøm; G E Andersen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-06       Impact factor: 3.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.